- Report
- February 2026
- 250 Pages
Global
From €4067EUR$4,490USD£3,509GBP
- Report
- April 2026
- 70 Pages
Global
From €4302EUR$4,750USD£3,712GBP
- Report
- July 2025
- 350 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- August 2025
- 100 Pages
Europe
From €3578EUR$3,950USD£3,087GBP
- Report
- July 2024
- 200 Pages
Global
From €4483EUR$4,949USD£3,868GBP
The Nut Allergy market is a subset of the Allergy and Immunology market, focusing on the diagnosis and treatment of allergies to nuts. Nut allergies are among the most common food allergies, and can cause a range of symptoms from mild to severe. Diagnosis is typically done through skin prick tests or blood tests, and treatment involves avoiding contact with the allergen and carrying an epinephrine auto-injector in case of anaphylaxis.
The Nut Allergy market is composed of a variety of companies, including pharmaceutical companies, diagnostic companies, and medical device companies. Pharmaceutical companies develop and market medications to treat allergies, while diagnostic companies develop and market tests to diagnose allergies. Medical device companies develop and market epinephrine auto-injectors and other devices to treat anaphylaxis. Examples of companies in the Nut Allergy market include Allergan, Novartis, Thermo Fisher Scientific, and Mylan. Show Less Read more